HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Venkatesh Pooladanda Selected Research

Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)

5/2021BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome.
1/2021iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome.
1/2019Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Venkatesh Pooladanda Research Topics

Disease

5Neoplasms (Cancer)
03/2024 - 12/2018
5Psoriasis (Pustulosis Palmaris et Plantaris)
04/2021 - 10/2017
4Inflammation (Inflammations)
04/2021 - 06/2019
3Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 01/2023
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
05/2021 - 01/2019
3Cytokine Release Syndrome
05/2021 - 10/2020
3Hyperplasia
10/2020 - 06/2019
2Splenomegaly
10/2020 - 06/2019
2Lung Neoplasms (Lung Cancer)
01/2020 - 11/2019
2Breast Neoplasms (Breast Cancer)
11/2019 - 09/2018
1Carcinoma (Carcinomatosis)
03/2024
1Melanoma (Melanoma, Malignant)
06/2023
1Neoplasm Metastasis (Metastasis)
06/2023
1Wounds and Injuries (Trauma)
06/2023
1Pneumonia (Pneumonitis)
01/2021
1Skin Diseases (Skin Disease)
10/2020
1Osteoporosis
10/2020
1COVID-19
08/2020
1Colonic Neoplasms (Colon Cancer)
11/2019
1Lung Injury
01/2019
1Edema (Dropsy)
01/2019

Drug/Important Bio-Agent (IBA)

4Imiquimod (Aldara)FDA LinkGeneric
04/2021 - 06/2019
3nimbolideIBA
01/2021 - 09/2018
2NiclosamideFDA Link
06/2023 - 01/2020
2PlatinumIBA
03/2023 - 01/2023
2LipopolysaccharidesIBA
05/2021 - 10/2020
2EndotoxinsIBA
01/2021 - 01/2019
2CytokinesIBA
10/2020 - 01/2019
2TriazolesIBA
01/2020 - 01/2019
1Immunoconjugates (Immunoconjugate)IBA
04/2024
1Conditioned Culture MediaIBA
03/2024
1Galectin 3 (LGALS3)IBA
03/2024
1Cadherins (E-Cadherin)IBA
06/2023
1VimentinIBA
06/2023
1AnthelminticsIBA
06/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2023
1Small Interfering RNA (siRNA)IBA
05/2021
1SeleniumIBA
04/2021
1N-end cysteine peptide tumor-homing peptideIBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
1Liposomes (Liposome)IBA
01/2021
1Rutin (Rutoside)IBA
10/2020
1piperlongumineIBA
10/2020
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
10/2020
1InterferonsIBA
08/2020
1DAPIIBA
01/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2020
1Matrix Metalloproteinases (MMPs)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1FITC-annexin A5IBA
01/2020
15,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
01/2020
1benzimidazoleIBA
01/2020
11-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1Galectin 1 (LGALS1)IBA
01/2020
1thiazolyl blueIBA
11/2019
1indoleIBA
11/2019
1Ambroxol (Mucosolvan)IBA
06/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1MorpholinesIBA
01/2019
1coumarinIBA
01/2019
1OxazolesIBA
12/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2018
1thymoquinoneIBA
10/2017

Therapy/Procedure

2Therapeutics
04/2021 - 08/2020
1Drug Therapy (Chemotherapy)
03/2023